Unannounced · 462 daysFiled 12 June 2025
Gradalis, Inc. raised $12.7M
Gradalis, Inc., a biotech company based in Carrollton, TX, raised $12.7M in a new debt round, according to a filing dated 12 June 2025.
No public announcement found as of 16 September 2026, 462 days after the filing.
- Filed
- 12 June 2025
- Round
- Debt round
- Amount sold
- $12.7M
- Offering size
- $30M
- Investors so far
- 24
- Based in
- Carrollton, TX
- Website
- gradalisinc.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 62% of the 1,404 tracked raises with an amount filed in 2025, and than 54% of the 112 in biotech.
Gradalis, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 12 Jun 2025 | New filing | $12.7M | This raise |
More with Sante Health Ventures on the board
- Reimagine Care, Inc.$2.42M
- Sensorium Therapeutics, Inc.$26.8M
- Molecular Templates, Inc.$20M
- Clairity, Inc.$6.67M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.